🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is an open label study followed by a randomised, double-blind, p...
Status
Unknown
Location
Centre Georges Grancois Leclerc
Start Date
2022-03-15
Trial ID
NCT05240131
Treatments Being Tested
The interventional, randomized, placebo-controlled, double-blind phase II-t...
Status
Recruiting
Location
University Hospital Heidelberg
Start Date
2025-07-16
Trial ID
NCT05690048
This study will evaluate the efficacy and safety of atezolizumab plus chemo...
Status
Completed
Location
Florida Cancer Specialists - Fort Myers (Broadway)
Start Date
2018-01-11
Trial ID
NCT03371017
Treatments Being Tested
This is a Phase III, global, double-blind, 2-arm randomized study designed ...
Status
Completed
Location
St. Joseph'S Hospital & Medical Center
Start Date
2017-03-08
Trial ID
NCT03038100
Treatments Being Tested
This is a multi-center study in patients with recurrent or metastatic HPV16...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-04-18
Trial ID
NCT06099418
Treatments Being Tested
This is a multicenter, double-blind, placebo-controlled, randomized, phase ...
Status
Terminated
Location
Beijing Cancer Hospital
Start Date
2021-12-01
Trial ID
NCT04308785
Treatments Being Tested
This randomized phase II trial studies how well capecitabine and bevacizuma...
Status
Completed
Location
Mayo Clinic Hospital
Start Date
2017-07-07
Trial ID
NCT02873195
Treatments Being Tested
This is a randomized, double-blinded study designed to evaluate the efficac...
Status
Completed
Location
Arizona Oncology
Start Date
2018-04-24
Trial ID
NCT03456063
The primary objective of this study is to evaluate the efficacy of atezoliz...
Status
Completed
Location
Moores Cancer Center at UC San Diego Health
Start Date
2021-03-02
Trial ID
NCT04665843
Treatments Being Tested
The purpose of this study is to evaluate the efficacy, safety, and pharmaco...
Status
Completed
Location
UCLA
Start Date
2020-12-15
Trial ID
NCT04619797